Vulcan ePI FHIR Implementation Guide
0.1.0 - CI Build

Vulcan ePI FHIR Implementation Guide - Local Development build (v0.1.0). See the Directory of published versions

: 56b3b73e-dba0-4447-b8cd-1e24ed637017 - JSON Representation

Raw json | Download


{
  "resourceType" : "RegulatedAuthorization",
  "id" : "56b3b73e-dba0-4447-b8cd-1e24ed637017",
  "meta" : {
    "profile" : [
      "http://hl7.org/fhir/uv/vulcan-epi/StructureDefinition/RegulatedAuthorization-uv-epi"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: RegulatedAuthorization</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource RegulatedAuthorization \"56b3b73e-dba0-4447-b8cd-1e24ed637017\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-RegulatedAuthorization-uv-epi.html\">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: id: 21400AMY00186 (OFFICIAL)</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-f1b25777-da7a-4a35-98af-ab18d3246d54.html\">MedicinalProductDefinition/f1b25777-da7a-4a35-98af-ab18d3246d54</a></p><p><b>type</b>: Marketing Authorisation <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (#/#100000072062)</span></p><p><b>region</b>: United States of America <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (unknown#us)</span></p><p><b>status</b>: Active <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-publication-status.html\">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2002-08-01 01:28:17+0000</p><p><b>holder</b>: <a href=\"Organization-85c5d81e-9d5a-4a15-8b9d-42bbbe0409c8.html\">Organization/85c5d81e-9d5a-4a15-8b9d-42bbbe0409c8</a> \"PHARMACIA &amp; UPJOHN COMPANY LLC\"</p></div>"
  },
  "identifier" : [
    {
      "use" : "official",
      "system" : "https://fda-approvalandlicenseno/",
      "value" : "21400AMY00186"
    }
  ],
  "subject" : [
    {
      "reference" : "MedicinalProductDefinition/f1b25777-da7a-4a35-98af-ab18d3246d54"
    }
  ],
  "type" : {
    "coding" : [
      {
        "system" : "https://spor.ema.europa.eu/rmswi/",
        "code" : "/#100000072062"
      }
    ],
    "text" : "Marketing Authorisation"
  },
  "region" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "us"
        }
      ],
      "text" : "United States of America"
    }
  ],
  "status" : {
    "coding" : [
      {
        "system" : "http://hl7.org/fhir/publication-status",
        "code" : "active"
      }
    ],
    "text" : "Active"
  },
  "statusDate" : "2002-08-01T13:28:17Z",
  "holder" : {
    "reference" : "Organization/85c5d81e-9d5a-4a15-8b9d-42bbbe0409c8"
  }
}